Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Stem cell transplantation shows promise for treating diseases but faces challenges like safety, ethics, and cost.

Immune-epithelial interactions are crucial for tissue repair, but unchecked can cause diseases.

Men are more likely to get infectious skin diseases, while women are more prone to autoimmune and pigment-related skin conditions, influenced by biological and environmental factors.

Targeting specific cell interactions may help treat skin fibrosis.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

KAP-depleted hair causes less immune response and is more biocompatible for implants.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Certain mice without specific receptors or mast cells don't lose hair from stress.

The skin's layers protect, sense, and regulate the body's internal balance, but can be prone to cancer.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Alopecia areata is caused by immune system attacks on hair follicles, often triggered by viral infections.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Skin stretching can improve vaccine delivery through hair follicles and boost immune response.

TSLP affects atopic dermatitis by increasing sebum and reducing fat through IL-4/IL-13 signaling.

PRF lysates reduce inflammation in cancer cells and boost immune response in healthy oral cells.

Nanoparticles can effectively enter hair follicles and stimulate immune responses, supporting potential transfollicular vaccination.

Macrophages are crucial for hair regrowth in contact hypersensitivity.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Special immune cells called Tregs can help prevent lung scarring by blocking a specific growth factor.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.